ClinicalTrials.gg

Innocoll clinical trials

Part of Gurnet Point L.P., which holds 100% as of 2017-07-24. Source

The registry lists 21 studies whose lead sponsor is Innocoll. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 13, 2023.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

What it is testing

The drugs Innocoll’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 21 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed1886%
  • Stopped early210%
  • Status unknown or other15%

Phase

  • Phase 210
  • Phase 39
  • Phase 11

Where

  • United States20
  • Netherlands2
  • Australia1
  • Hungary1
  • Czechia1
  • Denmark1

Over the years

  1. 07
  2. 608
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Innocoll.

  • Innocoll
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    21 studies

Focus areas

Conditions Innocoll leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 21 of 21.